Xenon Pharmaceuticals Inc (XENE)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: XENE Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-03-08 2022-03-04 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
6,710 -17.2%
30.56
205,058 USD 		6,710 -17.2% 30.56 205,058 USD
2022-03-08 2022-03-04 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,793 -2.2%
30.56
146,474 USD 		4,793 -2.2% 30.56 146,474 USD
2022-03-08 2022-03-04 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,532 -2.1%
30.66
138,951 USD 		4,532 -2.1% 30.66 138,951 USD
2022-01-21 2022-01-21 B Purchase

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

Officer
700 +inf%
28.81
20,167 USD 		700 +inf% 28.81 20,167 USD
2021-12-07 2021-12-06 B Purchase

Von Seggern Christopher

Chief Commercial Officer

Officer
4,000 +inf%
24.40
97,600 USD 		4,000 +inf% 24.40 97,600 USD
2021-11-16 2021-11-15 S Sale

PIMSTONE SIMON N.

Non-Executive Director
17,557 -7.7%
31.33
550,061 USD 		17,557 -7.7% 31.33 550,061 USD
2021-06-01 2021-05-28 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
2,912 -8.3%
18.81
54,775 USD 		2,912 -8.3% 18.81 54,775 USD
2021-06-01 2021-05-28 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
3,155 -8.2%
18.81
59,346 USD 		3,155 -8.2% 18.81 59,346 USD
2021-06-01 2021-05-27 S Sale

HOLLER FRANK A

Non-Executive Director
8,485 -5.6%
18.68
158,500 USD 		8,485 -5.6% 18.68 158,500 USD
2021-06-01 2021-05-27 S Sale

HOLLER FRANK A

Non-Executive Director
2,579 -1.7%
18.69
48,202 USD 		2,579 -1.7% 18.69 48,202 USD
2020-06-02 2020-06-01 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
3,000 -1.2%
14.43
43,290 USD 		3,000 -1.2% 14.43 43,290 USD
2020-06-02 2020-05-29 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
5,000 -1.9%
13.99
69,950 USD 		5,000 -1.9% 13.99 69,950 USD
2019-09-24 2019-09-20 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
10,395 -3.9%
9.51
98,856 USD 		10,395 -3.9% 9.51 98,856 USD
2019-09-20 2019-09-20 S Sale

HOLLER FRANK A

5,206 -4.2%
9.39
48,884 USD 		5,206 -4.2% 9.39 48,884 USD
2019-09-20 2019-09-19 S Sale

HOLLER FRANK A

7,600 -5.8%
9.27
70,452 USD 		7,600 -5.8% 9.27 70,452 USD
2019-09-18 2019-09-18 S Sale

HOLLER FRANK A

4,368 -3.2%
9.28
40,535 USD 		4,368 -3.2% 9.28 40,535 USD
2019-09-18 2019-09-17 S Sale

HOLLER FRANK A

5,069 -3.6%
9.32
47,243 USD 		5,069 -3.6% 9.32 47,243 USD
2019-09-17 2019-09-13 S Sale

AZAB MOHAMMAD

23 -0.0%
9.31
214 USD 		23 -0.0% 9.31 214 USD
2017-11-16 2017-11-15 B Purchase

AZAB MOHAMMAD

15,000 +51.4%
2.22
33,281 USD 		15,000 +51.4% 2.22 33,281 USD
2017-09-25 2017-09-22 B Purchase

AZAB MOHAMMAD

8,000 +37.7%
2.95
23,600 USD 		8,000 +37.7% 2.95 23,600 USD
2017-09-25 2017-09-21 B Purchase

AZAB MOHAMMAD

2,000 +10.4%
2.95
5,900 USD 		2,000 +10.4% 2.95 5,900 USD
2017-08-21 2017-08-18 B Purchase

WINQUIST RAYMOND

Head, Translational Research
1,000 +inf%
3.00
2,995 USD 		1,000 +inf% 3.00 2,995 USD
2017-08-21 2017-08-18 B Purchase

AZAB MOHAMMAD

6,312 +48.9%
2.90
18,302 USD 		6,312 +48.9% 2.90 18,302 USD
2017-08-21 2017-08-17 B Purchase

AZAB MOHAMMAD

23 +0.2%
2.65
61 USD 		23 +0.2% 2.65 61 USD
2017-08-17 2017-08-15 B Purchase

EMPFIELD JAMES R.

SVP, Drug Discovery
10,000 +inf%
2.48
24,824 USD 		10,000 +inf% 2.48 24,824 USD
2017-08-16 2017-08-15 B Purchase

BVF PARTNERS L P/IL

Major owner
7,429 +0.7%
2.41
17,920 USD 		7,429 +0.7% 2.41 17,920 USD
2017-08-16 2017-08-15 B Purchase

BVF PARTNERS L P/IL

Major owner
11,429 +0.7%
2.41
27,569 USD 		11,429 +0.7% 2.41 27,569 USD
2017-08-16 2017-08-14 B Purchase

BVF PARTNERS L P/IL

Major owner
13,337 +1.3%
2.70
36,058 USD 		13,337 +1.3% 2.70 36,058 USD
2017-08-16 2017-08-14 B Purchase

BVF PARTNERS L P/IL

Major owner
28,007 +1.7%
2.70
75,720 USD 		28,007 +1.7% 2.70 75,720 USD
2017-08-15 2017-08-14 B Purchase

Svoronos Dawn

50,000 +inf%
2.82
140,770 USD 		50,000 +inf% 2.82 140,770 USD
2017-08-14 2017-08-14 B Purchase

Hayden Michael R

15,000 +10.3%
2.75
41,247 USD 		15,000 +10.3% 2.75 41,247 USD
2017-08-14 2017-08-11 B Purchase

GANNON STEVEN

15,000 +inf%
2.82
42,267 USD 		15,000 +inf% 2.82 42,267 USD
2017-08-14 2017-08-10 B Purchase

MORTIMER IAN

CFO & COO
10,000 +232.6%
2.90
29,000 USD 		10,000 +232.6% 2.90 29,000 USD
2017-08-14 2017-08-10 B Purchase

MORTIMER IAN

CFO & COO
5,000 +500.0%
2.85
14,225 USD 		5,000 +500.0% 2.85 14,225 USD
2017-08-14 2017-08-10 B Purchase

SCHELLER RICHARD H

7,000 +inf%
2.85
19,950 USD 		7,000 +inf% 2.85 19,950 USD
2017-08-14 2017-08-10 B Purchase

PATOU GARY

7,500 +150.0%
2.78
20,836 USD 		7,500 +150.0% 2.78 20,836 USD
2017-08-14 2017-08-10 B Purchase

PIMSTONE SIMON N.

President & CEO

Executive Director
6,000 +2.8%
2.90
17,400 USD 		6,000 +2.8% 2.90 17,400 USD
2017-08-10 2017-08-08 B Purchase

PATOU GARY

5,000 +inf%
3.00
15,003 USD 		5,000 +inf% 3.00 15,003 USD
2017-06-29 2017-06-27 B Purchase

BVF PARTNERS L P/IL

Major owner
8,496 +2.9%
4.00
33,984 USD 		8,496 +2.9% 4.00 33,984 USD
2017-06-29 2017-06-27 B Purchase

BVF PARTNERS L P/IL

Major owner
30,170 +2.9%
4.00
120,680 USD 		30,170 +2.9% 4.00 120,680 USD
2017-06-29 2017-06-27 B Purchase

BVF PARTNERS L P/IL

Major owner
46,795 +2.9%
4.00
187,180 USD 		46,795 +2.9% 4.00 187,180 USD
2017-06-23 2017-06-22 B Purchase

BVF PARTNERS L P/IL

Major owner
854 +0.3%
4.00
3,416 USD 		854 +0.3% 4.00 3,416 USD
2017-06-23 2017-06-22 B Purchase

BVF PARTNERS L P/IL

Major owner
2,884 +0.3%
4.00
11,536 USD 		2,884 +0.3% 4.00 11,536 USD
2017-06-23 2017-06-22 B Purchase

BVF PARTNERS L P/IL

Major owner
4,525 +0.3%
4.00
18,100 USD 		4,525 +0.3% 4.00 18,100 USD
2017-06-23 2017-06-21 B Purchase

BVF PARTNERS L P/IL

Major owner
1,362 +0.5%
4.00
5,448 USD 		1,362 +0.5% 4.00 5,448 USD
2017-06-23 2017-06-21 B Purchase

BVF PARTNERS L P/IL

Major owner
4,406 +0.4%
4.00
17,624 USD 		4,406 +0.4% 4.00 17,624 USD
2017-06-23 2017-06-21 B Purchase

BVF PARTNERS L P/IL

Major owner
6,380 +0.4%
4.00
25,520 USD 		6,380 +0.4% 4.00 25,520 USD
2017-06-19 2017-06-19 B Purchase

BVF PARTNERS L P/IL

Major owner
357 +0.1%
3.85
1,374 USD 		357 +0.1% 3.85 1,374 USD
2017-06-19 2017-06-19 B Purchase

BVF PARTNERS L P/IL

Major owner
1,271 +0.1%
3.85
4,893 USD 		1,271 +0.1% 3.85 4,893 USD
2017-06-19 2017-06-19 B Purchase

BVF PARTNERS L P/IL

Major owner
1,967 +0.1%
3.85
7,573 USD 		1,967 +0.1% 3.85 7,573 USD
2017-06-19 2017-06-16 B Purchase

BVF PARTNERS L P/IL

Major owner
1,064 +0.4%
3.85
4,096 USD 		1,064 +0.4% 3.85 4,096 USD
2017-06-19 2017-06-16 B Purchase

BVF PARTNERS L P/IL

Major owner
3,873 +0.4%
3.85
14,911 USD 		3,873 +0.4% 3.85 14,911 USD
2017-06-19 2017-06-16 B Purchase

BVF PARTNERS L P/IL

Major owner
6,097 +0.4%
3.85
23,473 USD 		6,097 +0.4% 3.85 23,473 USD
2017-06-19 2017-06-15 B Purchase

BVF PARTNERS L P/IL

Major owner
1,160 +0.4%
3.84
4,451 USD 		1,160 +0.4% 3.84 4,451 USD
2017-06-19 2017-06-15 B Purchase

BVF PARTNERS L P/IL

Major owner
3,845 +0.4%
3.84
14,753 USD 		3,845 +0.4% 3.84 14,753 USD
2017-06-19 2017-06-15 B Purchase

BVF PARTNERS L P/IL

Major owner
6,774 +0.4%
3.84
25,992 USD 		6,774 +0.4% 3.84 25,992 USD
2017-06-08 2017-06-07 B Purchase

BVF PARTNERS L P/IL

Major owner
20,594 +7.8%
3.85
79,312 USD 		20,594 +7.8% 3.85 79,312 USD
2017-06-08 2017-06-07 B Purchase

BVF PARTNERS L P/IL

Major owner
73,749 +7.9%
3.85
284,022 USD 		73,749 +7.9% 3.85 284,022 USD
2017-06-08 2017-06-07 B Purchase

BVF PARTNERS L P/IL

Major owner
113,446 +7.8%
3.85
436,903 USD 		113,446 +7.8% 3.85 436,903 USD
2017-06-08 2017-06-06 B Purchase

BVF PARTNERS L P/IL

Major owner
913 +0.3%
3.75
3,424 USD 		913 +0.3% 3.75 3,424 USD
2017-06-08 2017-06-06 B Purchase

BVF PARTNERS L P/IL

Major owner
53,260 +6.0%
3.75
199,725 USD 		53,260 +6.0% 3.75 199,725 USD
2017-06-08 2017-06-06 B Purchase

BVF PARTNERS L P/IL

Major owner
96,736 +7.2%
3.75
362,760 USD 		96,736 +7.2% 3.75 362,760 USD
2016-12-19 2016-12-15 S Sale

HOLLER FRANK A

Non-Executive Director
30,000 -20.6%
7.85
235,500 USD 		30,000 -20.6% 7.85 235,500 USD
2016-08-23 2016-08-19 S Sale

HOLLER FRANK A

Non-Executive Director
11,938 -7.6%
7.65
91,338 USD 		11,938 -7.6% 7.65 91,338 USD
2016-08-18 2016-08-18 S Sale

HOLLER FRANK A

Non-Executive Director
9,599 -5.7%
7.70
73,912 USD 		9,599 -5.7% 7.70 73,912 USD
2016-08-18 2016-08-17 S Sale

HOLLER FRANK A

Non-Executive Director
1,600 -0.9%
7.89
12,624 USD 		1,600 -0.9% 7.89 12,624 USD
2016-08-18 2016-08-16 S Sale

HOLLER FRANK A

Non-Executive Director
6,863 -3.9%
8.25
56,620 USD 		6,863 -3.9% 8.25 56,620 USD
2016-06-28 2016-06-24 B Purchase

MORTIMER IAN

CFO & COO

Officer
1,300 +43.3%
6.30
8,190 USD 		1,300 +43.3% 6.30 8,190 USD
2016-06-28 2016-06-24 B Purchase

MORTIMER IAN

CFO & COO

Officer
2,000 +200.0%
6.25
12,500 USD 		2,000 +200.0% 6.25 12,500 USD
2016-06-28 2016-06-24 B Purchase

MORTIMER IAN

CFO & COO

Officer
1,000 +inf%
6.10
6,100 USD 		1,000 +inf% 6.10 6,100 USD
2016-06-28 2016-06-24 B Purchase

MORTIMER IAN

CFO & COO

Officer
1,000 +inf%
6.15
6,150 USD 		1,000 +inf% 6.15 6,150 USD
2015-09-24 2015-09-24 S Sale

GOLDBERG Y. PAUL

VP of Clinical Development

Officer
12,000 -66.7%
8.60
103,200 USD 		12,000 -66.7% 8.60 103,200 USD
2015-09-24 2015-09-23 S Sale

GOLDBERG Y. PAUL

VP of Clinical Development

Officer
4,000 -18.2%
9.02
36,080 USD 		4,000 -18.2% 9.02 36,080 USD
2015-09-24 2015-09-22 S Sale

GOLDBERG Y. PAUL

VP of Clinical Development

Officer
6,149 -21.8%
9.33
57,384 USD 		6,149 -21.8% 9.33 57,384 USD